Epaderm emollient

Epaderm is a well-established medical-grade emollient range specifically formulated for the management of dry skin conditions such as eczema and psoriasis. The brand's history dates back to the 1970s, when it was originally developed by dermatologists at the Royal Victoria Infirmary in Newcastle upon Tyne, UK, to treat babies suffering from severe eczema.

Today, Epaderm products, including creams and ointments, are manufactured in the United Kingdom using globally sourced ingredients. The brand has evolved from a specialist hospital-developed remedy into a widely available consumer and clinical skin care solution.

The brand is owned by Mölnlycke Health Care, a leading global MedTech company headquartered in Sweden. Mölnlycke acquired the brand as part of its skin and wound care portfolio. The company itself is part of Investor AB, the Swedish investment firm founded by the Wallenberg family. Epaderm remains a key product in the pharmacy and hospital channels across Europe and Australia, often prescribed by healthcare professionals for its minimalist, irritation-free formulation.